ONS ONCC Chemo Renewal Exam ||Verified Exam!!||
Most Recent Exam 2026 Actual Complete Real Exam
Questions And Correct Answers (Verified Answers)
Already Graded A+ | Assured Success!! Newest
Exam!!
_____________can cause blistering and significant pain
and tissue damage and destruction, leading to tissue
death. - Answer-Vesicants
A further classification of an antineoplastic agent's
potential to cause damage is whether its mechanism of
action includes DNA binding. - Answer-Non-DNA-binding
solutions remain in the local area of the extravasation,
which improves the possibility of drug deactivation.
DNA-binding agents attach to DNA nucleic acids, causing
the antagonist to be ingested cellularly, leading to
progressive tissue destruction
DNA Binding Irritants - Answer-Bendamustinea
Dactinomycin
Daunorubicin
Doxorubicin
,2|Page
Epirubicin
Idarubicin
Mechlorethamine
Mitomycin
DNA Nonbinding vessicants - Answer-Amsacrine
Paclitaxel
Vinblastine
Vincristine
Vindesine
Vinorelbine
Extravasciation Alkylating / Mechlorethamine tx - Answer-
Sodium thiosulfate
Inject 2 ml of sodium thiosulfate for each milligram of
mechlorethamine extravasated.
Inject subcutaneously into extravasation site using a 25
gauge or smaller needle (change needle with each
injection).
Monitor extravasation site according to the institution's
, 3|Page
policies and procedures.
Extravasciation Alkylating: Oxaliplatin - Answer-Apply
warm compresses.
Dexamethasone
8 mg twice daily
for 14 days
Main benefit of neoadjuvant chemotherapy (breast cancer
patient) - Answer-Neoadjuvant therapy does not increase
survival when compared to adjuvant therapy. It only
changes the timing of treatment and can change surgical
options if the tumor is shrunk enough. If this occurs, the
patient may only require a lumpectomy plus radiation
therapy instead of needing a mastectomy
Due to Mrs. Turner's age and comorbidities, her oncologist
performs a comprehensive geriatric assessment. You
know that this assessment covers all but which of the
following: - Answer-A comprehensive geriatric assessment
(CGA) is a multidisciplinary evaluation to assess life
expectancy and risk of morbidity and mortality in the older
patient. This assessment tool would evaluate and include
the following areas: functional status, socioeconomic
issues, psychosocial distress, comorbidities, cognitive